Evidence map›Paper›PMID 24849324›Full record

ArticlePharmacogenetics and genomics2014

PharmGKB summary: tramadol pathway.

Li Gong, Ulrike M Stamer, Mladen V Tzvetkov, Russ B Altman, Teri E Klein

Abstract read
In one paragraph

Article in Pharmacogenetics and genomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. The Pharmacogenetics of Tramadol.Clinical pharmacokinetics · 2015
    Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Review
  10. Role of Pharmacogenetics on Tramadol Pharmacokinetics: A Population Pharmacokinetic Model.European journal of drug metabolism and pharmacokinetics · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Li GongDepartments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Anaesthesiology and Pain Medicine, Inselspital dDepartment of Clinical Research, University of Bern, Bern, Switzerland eInstitute of Clinical Pharmacology, University Medical Center, Göttingen, Germany.
Ulrike M Stamer
Mladen V Tzvetkov
Russ B Altman
Teri E Klein

Funding

PharmGKB: pharmacogenomics knowledge for precision medicineR24GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO, KLEIN, TERI ELLEN · 2010 to 2018
$25.2M
THE STANFORD PHARMACOGENETICS KNOWLEDGE BASEU01GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO · 2000 to 2009
$24.0M
NIGMS NIH HHS R24 GM061374NIGMS NIH HHS U01 GM061374NIGMS NIH HHS U01GM61374
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesAnalgesicsBiological TransportCytochrome P-450 CYP2D6Genetic VariationHumansPainPharmacogeneticsPolymorphism, GeneticReceptors, Opioid, muTramadolAnalgesicsCytochrome P-450 CYP2D6Receptors, Opioid, muTramadol

Identifiers

PMID24849324
PMCPMC4100774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.